Pine Valley Investments LTD Liability CO Indaptus Therapeutics, Inc. Transaction History
Pine Valley Investments LTD Liability CO
- $1.65 Trillion
- Q3 2024
A detailed history of Pine Valley Investments LTD Liability CO transactions in Indaptus Therapeutics, Inc. stock. As of the latest transaction made, Pine Valley Investments LTD Liability CO holds 43,983 shares of INDP stock, worth $37,385. This represents 0.0% of its overall portfolio holdings.
Number of Shares
43,983
Previous 44,085
0.23%
Holding current value
$37,385
Previous $93.5 Million
41.65%
% of portfolio
0.0%
Previous 0.01%
Shares
5 transactions
Others Institutions Holding INDP
# of Institutions
18Shares Held
605KCall Options Held
0Put Options Held
0-
Vanguard Group Inc Valley Forge, PA256KShares$217,8250.0% of portfolio
-
Investment House LLC Las Vegas, NV100KShares$84,9790.01% of portfolio
-
Geode Capital Management, LLC Boston, MA73.1KShares$62,1590.0% of portfolio
-
Strategy Asset Managers LLC45.3KShares$38,5350.01% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny27.1KShares$23,0350.0% of portfolio
About Indaptus Therapeutics, Inc.
- Ticker INDP
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 8,258,600
- Market Cap $7.02M
- Description
- Indaptus Therapeutics, Inc., a pre-clinical biotechnology company, develops various anti-cancer and anti-viral immunotherapy products. Its lead clinical oncology candidate is Decoy20 to single agent activity and/or combination therapy-based durable responses of lymphoma, hepatocellular, colorectal, and pancreatic tumors, as well as hepatitis B v...